Anakinra for the management of resistant idiopathic recurrent pericarditis. Initial experience in 10 adult cases

Annals of the Rheumatic Diseases

Volumn 73, Issue 12, 2014, Pages 2215-2217

  Lazaros, George ^a   Vasileiou, Panagiotis ^a   Koutsianas, Christos ^a   Antonatou, Katerina ^a   Stefanadis, Christodoulos ^a   Pectasides, Dimitrios ^a   Vassilopoulos, Dimitrios ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; C REACTIVE PROTEIN; COLCHICINE; CORTICOSTEROID; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; ANTIRHEUMATIC AGENT; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ADULT; AGED; CLINICAL ARTICLE; DISEASE DURATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPERTRANSAMINASEMIA; INJECTION SITE REACTION; LETTER; MALE; MIDDLE AGED; PERICARDITIS; PRIORITY JOURNAL; RECURRENCE RISK; RESISTANT IDIOPATHIC RECURRENT PERICARDITIS; RETREATMENT; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; YOUNG ADULT; COHORT ANALYSIS; DRUG RESISTANCE; IMMUNOLOGY; RECURRENT DISEASE; TREATMENT OUTCOME;

ADULT; AGED; ANTIRHEUMATIC AGENTS; COHORT STUDIES; DRUG RESISTANCE; FEMALE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE; MIDDLE AGED; PERICARDITIS; RECURRENCE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84922214331     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2014-205990     Document Type: Letter

References (10)

1. Imazio M. Treatment of recurrent pericarditis. Expert Rev Cardiovasc Ther 2012;10:1165-72.
2. Lazaros G, Vlachopoulos C, Stefanadis C. Idiopathic recurrent pericarditis: searching for Ariadne's thread. Hellenic J Cardiol 2009;50:345-51.
3. Imazio M, Belli R, Brucato A, et al. Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, double-blind, placebo-controlled, randomised trial. Lancet 2014;383:2232-7.
4. Brucato A, Brambilla G, Moreo A, et al. Long-term outcomes in difficult-to-treat patients with recurrent pericarditis. Am J Cardiol 2006;98:267-71.
5. Maestroni S, Di Corato PR, Cumetti D, et al. Recurrent pericarditis: autoimmune or autoinflammatory? Autoimmun Rev 2012;12:60-5.
6. Dinarello CA, van der Meer JW. Treating inflammation by blocking interleukin-1 in humans. Semin Immunol 2013;25:469-84.
7. Vasileiou P, Tsioufis C, Lazaros G, et al. Interleukin-8 as a predictor of acute idiopathic pericarditis recurrences. A pilot study. Int J Cardiol 2014;172:e463-4.
8. Finetti M, Insalaco A, Cantarini L, et al. Long-term efficacy of interleukin-1 receptor antagonist (anakinra) in corticosteroid-dependent and colchicine-resistant recurrent pericarditis. J Pediatr 2014;164:1425-31.e1.
9. Picco P, Brisca G, Traverso F, et al. Successful treatment of idiopathic recurrent pericarditis in children with interleukin-1beta receptor antagonist (anakinra): an unrecognized autoinflammatory disease? Arthritis Rheum 2009;60:264-8.
10. Vassilopoulos D, Lazaros G, Tsioufis C, et al. Successful treatment of adult patients with idiopathic recurrent pericarditis with an interleukin-1 receptor antagonist (anakinra). Int J Cardiol 2012;160:66-8.